CHICAGO, IL – SourceOne™ Global Partners has announced it has entered into a long-term exclusive supply agreement with China’s premier raw material extraction and supply company, Chengdu Waggott Pharmaceutical Co., Ltd.
“One of the keys in any company’s success is the ability to plan for its future,” says Jesse Lopez, founder, president and CEO of SourceOne. “In the case of our signature compound, Sytrinol™, recent scientific findings, combined with steady growth in worldwide demand, have illuminated the need to ensure that this compound will not only be in steady supply now and in the future, but continues to be of exceptional quality.”
Chengdu Waggott is located in Sichuan Province, China’s renowned citrus growing area. Its location is critical in obtaining the freshest citrus peels necessary to obtain the polymethoxylated flavones (PMFs) at their pristine peak; citrus-derived polymethoxylated flavones are a key ingredient in Sytrinol™. “We chose to work with Chengdu Waggott based on its proven level of expertise, its esteemed worldwide reputation, and our mutually shared philosophy of building long-term partnerships to promote the use of science-backed compounds of natural origin for products targeted to human health and wellness,” Lopez states. “In addition, our team at SourceOne is impressed with Chengdu Waggott’s technological expertise, product development acumen and process development ingenuity, as well as its GMP facilities.”
“We are extremely pleased with our relationship with SourceOne Global Partners, as we believe its reputation for integrity and expertise in marketing is unsurpassed, and is complimentary to our technological and product development expertise,” comments Jun Hua, general manager of Chendu Wagott. We understand the importance of the plymethoxylated flavones component of Sytrinol™ and we have other proprietary products in our pipeline for which we will rely on SourceOne’s expertise to brand and introduce to the dietary supplement and functional foods market.
SytrinolTM is a powerful antioxidant with numerous heart health benefits including playing a significant role as an anti-inflammatory. Other heart health parameters being studied include C-reactive protein (CRP), apolipoprotein AI, and apolipoprotein B. Recent research is establishing that inflammation may cause C-reactive protein (CRP) to be produced in the body and is considered a reliable marker for sudden heart attack. Apolipoprotein AI is a major component of HDL and is associated with a decreased risk of cardiovascular disease, while apolipoprotein B is a major component of LDL and is associated with an increased risk of cardiovascular disease. Sytrinol™ contains specific compounds that are suggested to positively affect these reliable predictors of cardiovascular disease. SourceOne owns the exclusive worldwide license for the intellectual property associated with SytrinolTM
About SourceOneTM Global Partners
SourceOne was conceived as a company whose core competence is to integrate legitimate science with strong trade and consumer branding. SourceOne™ Global Partners cultivates relationships with leading suppliers worldwide to source and offer patented ingredients supported by proprietary science as part of a turnkey marketing program that dramatically increases the odds for marketing success.